Related Experiment Video
Updated: Aug 20, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma
Sajeev K Puri1, Lingbao Si, Chun-Yang Fan
1Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA. purisajeevk@uams.edu
Purpose:
Epigenetic alteration, via promoter hypermethylation, inactivates genes important for the development of head and neck squamous cell carcinoma (SCCHN). The aim of this study is to characterize and correlate, with clinical parameters, the promoter methylation profile of DNA repair genes, hMLH1 and O6-methylguanine-DNA methyltransferase (MGMT), and tumor-suppressor gene p16.
Materials And Methods:
Fifty-one cases of SCCHN, collected from the paraffin block archives (1997-1999) in the Department of Pathology at the University of Arkansas for medical sciences, provided DNA for methylation-specific PCR using primers specific for hMLH1, MGMT, and p16.
Results:
Sixty-two percent displayed promoter hypermethylation in at least one gene, with 23% seen for hMLH1, 30% for MGMT, and 36% for p16. Promoter hypermethylation of these genes separately or in combination was not associated with history of smoking and alcohol use, tumor size, nodal status, clinical stage, and overall survival. Promoter hypermethylation of more than 1 gene was significantly associated with increased 2-year disease-free survival. The probability of surviving 2 years without tumor recurrence was 100% with promoter hypermethylation in 2 or 3 genes and 46% with promoter hypermethylation in none or just 1 gene (P=.013). Promoter hypermethylation of 2 or 3 genes was independently related to increased 2-year cumulative disease-free survival (P=.028).
Conclusions:
Promoter hypermethylation of hMLH1, MGMT, and p16 genes was commonly detected in 47 SCCHN cases with up to 65% showing aberrant promoter hypermethylation in at least 1 gene. Promoter hypermethylation of 2 or 3 genes was significantly associated with increased 2-year disease-free survival, suggesting that promoter hypermethylation of multiple genes might improve survival. Significant correlation was also noted between a positive alcohol use history and promoter hypermethylation of the MGMT gene with no promoter hypermethylation of the p16 gene.
Insights
Promoter hypermethylation of DNA repair and tumor-suppressor genes is common in head and neck cancer. Hypermethylation of multiple genes, including hMLH1, MGMT, and p16, significantly improves disease-free survival.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Epigenetic alterations, specifically promoter hypermethylation, are crucial in the development of head and neck squamous cell carcinoma (SCCHN).
- This process can inactivate critical genes involved in tumor suppression and DNA repair.
Purpose of the Study:
- To characterize the promoter methylation profiles of DNA repair genes (hMLH1, MGMT) and the tumor-suppressor gene (p16) in SCCHN.
- To correlate these methylation profiles with clinical parameters and patient survival.
Main Methods:
- DNA was extracted from 51 SCCHN tissue samples.
- Methylation-specific PCR was employed to analyze promoter hypermethylation of hMLH1, MGMT, and p16 genes.
Main Results:
- Aberrant promoter hypermethylation was detected in at least one gene in 62% of SCCHN cases.
- Hypermethylation rates were 23% for hMLH1, 30% for MGMT, and 36% for p16.
- Hypermethylation of two or more genes was significantly associated with improved 2-year disease-free survival (100% vs. 46%).
Conclusions:
- Promoter hypermethylation of hMLH1, MGMT, and p16 is a frequent event in SCCHN.
- The hypermethylation of multiple genes (2 or 3) is a significant predictor of improved disease-free survival.
- A correlation was observed between alcohol use history and MGMT gene hypermethylation.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Cancers Originate from Somatic Mutations in a Single Cell
